Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andrew SE, Goldberg YP, Kremer B, Squitieri F, Theilmann J, Zeisler J, Telenius H, Adam S, Almquist E, Anvret M, Lucotte G, Stoessl AJ, Campanella G, Hayden MR (1994) Huntington disease without CAG expansion: Phenocopies or errors in assignment? Am J Hum Genet 54:852–863
Bahl S, Virdi K, Mittal U, Sachdeva M, Kalla A, Holmes SE, O’Hearn E, Margolis RL, Jain S, Srivastava AK, Mukerji M (2005) Evidence of a common founder for SCA12 in the Indian population. Ann Hum Genet 69:528–534
Bauer I, Gencik M, Laccone F, Peters H, Weber BH, Feder EH, Weirich H, Morris-Rosendahl DJ, Rolfs A, Gencikova A, Bauer P, Wenning GK, Epplen JT, Holmes SE, Margolis RL, Ross CA, Riess O (2002) Trinucleotide repeat expansions in the junctophilin-3 gene are not found in Caucasian patients with a Huntington’s disease-like phenotype. Ann Neurol 51:662
Brais B, Bourchard JP, Xie YG, Rochefort DL, Chretien N, Tome FM, LaFreniere RG, Rommens JM, Uyama E, Nohira O, Blumen S, Korcyn AD, Heutink P, Mathieu J, Duranceau A, Codere F, Fardeau M, Rouleau GA (1998) Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 18:164–167
Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Davies J, Shelbourne P, Buxton J, Jones C, Juvonen V, Johnson K, Harper PS, Shaw DJ, Housman DE (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68:799–808
Brusco A, Gellera C, Cagnoli C, Saluto A, Castucci A, Michielotto C, Fetoni V, Mariotti C, Migone N, Di Donato S, Taroni F (2004) Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families. Arch Neurol 61:727–733
Cholfin JA, Sobrido MJ, Perlman S, Pulst SM, Geschwind DH (2001) The SCA12 mutation as a rare cause of spinocerebellar ataxia. Arch Neurol 58:1833–1835
Dagda RK, Zaucha JA, Wadzinski BE, Strack S (2003) A developmentally regulated, neuron-specific splice variant of the variable subunit Bbeta targets protein phosphatase 2A to mitochondria and modulates apoptosis. J Biol Chem 278:24976–24985
Davis BM, McCurrach ME, Taneja KL, Singer RH, Housman DE (1997) Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc Natl Acad Sci USA 94:7388–7393
Dorsman JC, Pepers B, Langenberg D, Kerkdijk H, Ijszenga M, Den Dunnen JT, Roos RA, van Ommen GJ (2002) Strong aggregation and increased toxicity of polyleucine over polyglutamine stretches in mammalian cells. Hum Mol Genet 11:1487–1496
Fardaei M, Rogers MT, Thorpe HM, Larkin K, Hamshere MG, Harper PS, Brook JD (2002) Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet 11:805–814
Ferrigno P, Langan TA, Cohen P (1993) Protein phosphatase 2A1 is the major enzyme in vertebrate cell extracts that dephosphorylates several physiological substrates for cyclin-dependent protein kinases. Mol Biol Cell 4:669–677
Fu Y-H, Pizzuti A, Fenwick RG, King J, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, De Jong P, Wieringa B, Korneluk R, Perryman MB, Epstein HF, Caskey CT (1992) An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255:1256–1258
Fujigasaki H, Uchihara T, Koyano S, Iwabuchi K, Yagishita S, Makifuchi T, Nakamura A, Ishida K, Toru S, Hirai S, Ishikawa K, Tanabe T, Mizusawa H (2000) Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains. Exp Neurol 165:248–256
Fujigasaki H, Verma IC, Camuzat A, Margolis RL, Zander C, Lebre AS, Jamot L, Saxena R, Anand I, Holmes SE, Ross CA, Durr A, Brice A (2001) SCA12 is a rare locus for autosomal dominant cerebellar ataxia: a study of an Indian family. Ann Neurol 49:117–121
Gong CX, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, Iqbal K (2000) Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer’s disease. J Biol Chem 275:5535–5544
Hellenbroich Y, Kaulich M, Opitz S, Schwinger E, Zuhlke C (2004) No association of the SCA1 (CAG)31 allele with Huntington’s disease, myotonic dystrophy type 1 and spinocerebellar ataxia type 3. Psychiatr Genet 14:61–63
Holmes SE, O’Hearn EE, McInnis MG, Gorelick-Feldman DA, Kleiderlein JJ, Callahan C, Kwak NG, Ingersoll-Ashworth RG, Sherr M, Sumner AJ, Sharp AH, Ananth U, Seltzer WK, Boss MA, Vieria-Saecker AM, Epplen JT, Riess O, Ross CA, Margolis RL (1999) Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12. Nat Genet 23:391–392
Holmes SE, Hearn EO, Ross CA, Margolis RL (2001a) SCA12: an unusual mutation leads to an unusual spinocerebellar ataxia. Brain Res Bull 56:397–403
Holmes SE, O’Hearn E, Rosenblatt A, Callahan C, Hwang HS, Ingersoll-Ashworth RG, Fleisher A, Stevanin G, Brice A, Potter NT, Ross CA, Margolis RL (2001b) A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington diseaselike 2. Nat Genet 29:377–378
Holmes SE, O’Hearn E, Brahmachari SK, Choudhry S, Srivastava AK, Jain S, Ross CA, Margolis RL (2003) SCA12. In: Pulst S-M (ed) Genetics of movement disorder. Academic, San Diego, pp 121–130
Huntington’s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72:971–983
Ince TA, Scotto KW (1995) A conserved downstream element defines a new class of RNA polymerase II promoters. J Biol Chem 270:30249–30252
Ito K, Komazaki S, Sasamoto K, Yoshida M, Nishi M, Kitamura K, Takeshima H (2001) Deficiency of triad junction and contraction in mutant skeletal muscle lacking junctophilin type 1. J Cell Biol 154:1059–1067
Janssens V, Goris J, van Hoof C (2005) PP2A: the expected tumor suppressor. Curr Opin Genet Dev 15:34–41
Jiang H, Mankodi A, Swanson MS, Moxley RT, Thornton CA (2004) Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. HumMol Genet 13:3079–3088
Koob MD, Benzow KA, Bird TD, Day JW, Moseley ML, Ranum LP (1998) Rapid cloning of expanded trinucleotide repeat sequences from genomic DNA. Nat Genet 18:72–75
Koob MD, Moseley ML, Schut LJ, Benzow KA, Bird TD, Day JW, Ranum LPW (1999) An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat Genet 21:379–384
Krause A, Temlett J, van der Meyden J, Ross CA, Callahan C, Margolis R (2002) CAG/CTG repeat expansions at the HDL2 locus are a common cause of Huntington disease in Black South Africans. Am J Hum Genet, p 528
Lalioti MD, Scott HS, Buresi C, Rossier C, Bottani A, Morris MA, Malafosse A, Antonarakis SE (1997) Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature 386:847–851
Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293:864–867
Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Nelville C, Narang M, Barcelo J, O’Hoy K, Leblond S, Earle-MacDonald J, DeJong PJ, Wieringa B, Korneluk RG (1992) Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255:1253–1255
Mankodi A, Logigian E, Callahan L, McClain C, White R, Henderson D, Krym M, Thornton CA (2000) Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289:1769–1773
Mankodi A, Teng-umnuay P, Krym M, Henderson D, Swanson M, Thornton CA (2003) Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2. Ann Neurol 54:760–768
Mankodi A, Urbinati CR, Yuan QP, Moxley RT, Sansone V, Krym M, Henderson D, Schalling M, Swanson MS, Thornton CA (2001) Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum Mol Genet 10:2165–2170
Margolis RL, Ross CA (2001) Expansion explosion: new clues to the pathogenesis of repeat expansion neurodegenerative diseases. Trends Mol Med 7:479–482
Margolis RL, O’Hearn E, Rosenblatt A, Willour V, Holmes SE, Franz ML, Callahan C, Hwang HS, Troncoso JC, Ross CA (2001) A disorder similar to Huntington’s disease is associated with a novel CAG repeat expansion. Ann Neurol 50:373–380
Margolis RL, Holmes SE, Rosenblatt A, Gourley L, O’Hearn E, Ross CA, Seltzer WK, Walker RH, Ashizawa T, Rasmussen A, Hayden M, Almqvist EW, Harris J, Fahn S, MacDonald ME, Mysore J, Shimohata T, Tsuji S, Potter N, Nakaso K, Adachi Y, Nakashima K, Bird T, Krause A, Greenstein P (2004a) Huntington’s disease-like 2 (HDL2) in North America and Japan. Ann Neurol 56:670–674
Margolis RL, O’Hearn E, Holmes SE, Srivastava AK, Mukherji M, Sinha KK (2004b) Spinocerebellar ataxia type 12. Gene Clinics www.geneclinics.org
Maruyama H, Izumi Y, Morino H, Oda M, Toji H, Nakamura S, Kawakami H (2002) Difference in disease-free survival curve and regional distribution according to subtype of spinocerebellar ataxia: a study of 1286 Japanese patients. Am J Med Genet 114:578–583
Matsumura R, Futamura N, Ando N, Ueno S (2003) Frequency of spinocerebellar ataxia mutations in the Kinki district of Japan. Acta Neurol Scand 107:38–41
Mayer RE, Hendrix P, Cron P, Mattheis R, Stone SR, Goris J, Merlevede W, Hofsteenge J, Hemmings BA (1991) Structure of the 55-kDa regulatory subunit of protein phosphatase 2A: evidence for a neuronal-specific isoform. Biochem J 30:3589–3597
McCright B, Rivers AM, Audlin S, Virshup DM (1996) The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm. J Biol Chem 271:22081–22089
Miller JW, Urbinati CR, Teng-umnuay P, Stenberg MG, Byrne BJ, Thornton CA, Swanson MS (2000) Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J 19:4439–4448
Millward TA, Zolnierowicz S, Hemmings BA (1999) Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 24:186–191
Moore RC, Xiang F, Monaghan J, Han D, Zhang Z, Edstrom L, Anvret M, Prusiner SB (2001) Huntington disease phenocopy is a familial prion disease. Am J Hum Genet 69:1385–1388
Nishi M, Mizushima A, Nakagawara K, Takeshima H (2000) Characterization of human junctophilin subtype genes. Biochem Biophys Res Commun 273:920–927
Nishi M, Sakagami H, Komazaki S, Kondo H, Takeshima H (2003) Coexpression of junctophilin type 3 and type 4 in brain. Brain Res Mol Brain Res 118:102–110
O’Hearn E, Holmes SE, Calvert PC, Ross CA, Margolis RL (2001) SCA-12: Tremor with cerebellar and cortical atrophy is associated with a CAG repeat expansion. Neurology 56:299–303
O’Hearn E, Pletnikova O, Holmes SE, Trojanowski JQ, Margolis RL (2004) SCA12 Neuropathology: Cerebral cortical and cerebellar atrophy, Purkinje cell loss, and neuronal intranuclear inclusions. Mov Disord 19:1124
Persichetti F, Srinidhi J, Kanaley L, Ge P, Myers RH, D’Arrigo K, Barnes GT, MacDonald ME, Vonsattel JP, Gusella JF (1994) Huntington’s disease CAG trinucleotide repeats in pathologically confirmed post-mortem brains. Neurobiol Disord 1:159–166
Price NE, Mumby MC (1999) Brain protein serine/threonine phosphatases. Curr Opin Neurobiol 9:336–342
Rankin J, Wyttenbach A, Rubinsztein DC (2000) Intracellular green fluorescent proteinpolyalanine aggregates are associated with cell death. Biochem J 348 (Pt 1):15–19
Ranum LP, Day JW (2004) Pathogenic RNA repeats: an expanding role in genetic disease. Trends Genet 20:506–512
Rosenblatt A, Ranen NG, Rubinsztein DC, Stine OC, Margolis RL, Wagster MV, Becher MW, Rosser AE, Leggo J, Hodges JR, French-Constant CK, Sherr M, Franz ML, Abbott MH, Ross CA (1998) Patients with features similar to Huntington’s disease, without CAG expansion in huntingtin. Neurology 51:215–220
Santoro R, Grummt I (2001) Molecular mechanisms mediating methylation-dependent silencing of ribosomal gene transcription. Mol Cell 8:719–725
Sasaki H, Yabe I, Tashiro K (2003) The hereditary spinocerebellar ataxias in Japan. Cytogenet Genome Res 100:198–205
Schalling M, Hudson TJ, Buetow KW, Housman DE (1993) Direct detection of novel expanded trinucleotide repeats in the human genome. Nat Genet 4:135–139
Schmidt K, Kins S, Schild A, Nitsch RM, Hemmings BA, Gotz J (2002) Diversity, developmental regulation and distribution of murine PR55/B subunits of protein phosphatase 2A. Eur J Neurosci 16:2039–2048
Shimohata T, Onodera O, Honma Y, Hirota K, Nunomura Y, Kimura T, Kawachi I, Sanpei K, Nishizawa M, Tsuji S (2004) Gene diagnosis of patients with chorea. Rinsho Shinkeigaku 44:149–153
Shinagawa T, Ishiguro N, Horiuchi M, Matsui T, Okada K, Shinagawa M (1997) Deletion of c-myb exon 9 induced by insertion of repeats. Oncogene 14:2775–2783
Shiomi K, Takeichi M, Nishida Y, Nishi Y, Uemura T (1994) Alternative cell fate choice induced by low-level expression of a regulator of protein phosphatase 2A in the Drosophila peripheral nervous system. Development 120:1591–1599
Sinha KK, Worth PF, Jha DK, Sinha S, Stinton VJ, Davis MB, Wood NW, Sweeney MG, Bhatia KP (2004) Autosomal dominant cerebellar ataxia: SCA2 is the most frequent mutation in eastern India. J Neurol Neurosurg Psychiatry 75:448–452
Sontag E, Nunbhakdi-Craig V, Lee G, Bloom GS, Mumby MC (1996) Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A. Neuron 17:1201–1207
Sontag E, Nunbhakdi-Craig V, Lee G, Brandt R, Kamibayashi C, Kuret J, White CL3, Mumby MC, Bloom GS (1999) Molecular Interactions among Protein Phosphatase 2A, Tau, and Microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies. J Biol Chem 274:25490–25498
Srivastava AK, Choudhry S, Gopinath MS, Roy S, Tripathi M, Brahmachari SK, Jain S (2001) Molecular and clinical correlation in five Indian families with spinocerebellar ataxia 12. Ann Neurol 50:796–800
Stevanin G, Camuzat A, Holmes SE, Julien C, Sahloul R, Dode C, Hahn-Barma V, Ross CA, Margolis RL, Durr A, Brice A (2002) CAG/CTG repeat expansions at the Huntington’s disease-like 2 locus are rare in Huntington’s disease patients. Neurology 58:965–967
Stevanin G, Fujigasaki H, Lebre AS, Camuzat A, Jeannequin C, Dode C, Takahashi J, San C, Bellance R, Brice A, Durr A (2003) Huntington’s disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain 126:1599–1603
Strack S, Zaucha JA, Ebner FF, Colbran RJ, Wadzinski BE (1998) Brain protein phosphatase 2A: developmental regulation and distinct cellular and subcellular localization by B subunits. J Comp Neurol 392:515–527
Sulek A, Hoffman-Zacharska D, Bednarska-Makaruk M, Szirkowiec W, Zaremba J (2004) Polymorphism of trinucleotide repeats in non-translated regions of SCA8 and SCA12 genes: allele distribution in a Polish control group. J Appl Genet 45:101–105
Takeshima H, Komazaki S, Nishi M, Iino M, Kangawa K (2000) Junctophilins: a novel family of junctional membrane complex proteins. Mol Cell 6:11–22
Taneja KL, McCurrach M, Schalling M, Housman D, Singer RH (1995) Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol 128:995–1002
Tehrani MA, Mumby MC, Kamibayashi C (1996) Identification of a novel protein phosphatase 2A regulatory subunit highly expressed in muscle. J Biol Chem 271:5164–5170
Timchenko LT, Timchenko NA, Caskey CT, Roberts R (1996) Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy. Hum Mol Genet 5:115–121
Tolstykh T, Lee J, Vafai S, Stock JB (2000) Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits. EMBO J 19:5682–5691
Tsai HF, Liu CS, Leu TM, Wen FC, Lin SJ, Liu CC, Yang DK, Li C, Hsieh M (2004) Analysis of trinucleotide repeats in different SCA loci in spinocerebellar ataxia patients and in normal population of Taiwan. Acta Neurol Scand 109:355–360
Turowski P, Myles T, Hemmings BA, Fernandez A, Lamb NJ (1999) Vimentin dephosphorylation by protein phosphatase 2A is modulated by the targeting subunit B55. Mol Biol Cell 10:1997–2015
Virshup DM (2000) Protein phosphatase 2A: a panoply of enzymes. Curr Opin Cell Biol 12:180–185
Walker RH, Morgello S, Davidoff-Feldman B, Melnick A, Walsh MJ, Shashidharan P, Brin MF (2002) Autosomal dominant chorea-acanthocytosis with polyglutamine-containing neuronal inclusions. Neurology 58:1031–1037
Walker RH, Jankovic J, O’Hearn E, Margolis RL (2003) Phenotypic features of Huntington’s disease-like 2. Mov Disord 18:1527–1530
Worth PF, Wood NW (2001) Spinocerebellar ataxia type 12 is rare in the United Kingdom. Neurology 56:419–420
Xuereb JH, MacMillan JC, Snell R, Davies P, Harper PS (1996) Neuropathological diagnosis and CAG repeat expansion in Huntington’s disease. J Neurol Neurosurg Psychiatry 60:78–81
Zhao Y, Tan EK, Law HY, Yoon CS, Wong MC, Ng I (2002) Prevalence and ethnic differences of autosomal-dominant cerebellar ataxia in Singapore. Clin Genet 62:478–481
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Margolis, R.L. et al. (2006). Spinocerebellar Ataxia Type 12 and Huntington’s Disease-Like 2: Clues to Pathogenesis. In: Fry, M., Usdin, K. (eds) Human Nucleotide Expansion Disorders. Nucleic Acids and Molecular Biology, vol 19. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-33336-3_11
Download citation
DOI: https://doi.org/10.1007/3-540-33336-3_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-33335-7
Online ISBN: 978-3-540-33336-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)